At the start of 2023, U.S. patent exclusivity expired for the blockbuster drug Humira, AbbVie's chief cash cow. During the 20 ...

Artificial intelligence (AI) investing has been a major theme in the markets in 2023 and 2024, and will likely be a trend in ...

The FTSE 100 is expected to remain a battleground between buyers and sellers on a busy day for corporate reporting.

Asset & Wealth Management - another area where Goldman has traditionally been strong - also did well with revenue rising 16% ...

One of AB InBev's subsidiaries is another five-star stock, Ambev, the largest brewer in Latin America and the Caribbean. Like ...

I’ve been talking a lot with a weather predicting outfit called Weathertrends360 and their boss Bill Kirk. We were talking ...

A $500 investment is the same no matter how many shares you purchase or how high the share price, so don't feel relegated to ...

Electric vehicle stocks are falling Thursday after a report detailed the incoming Trump administration’s plans to axe a tax ...

Saudi Arabia’s wealth fund sold part of its stake in the kingdom’s main mobile-phone operator for about $1 billion, the ...

Cathie Wood's Ark Invest believes that could take its stock to $2,600 per share, a roughly eightfold gain in five years, as ...

Goldman Sachs created a stir in October with forecasts based on Nobel Laureate Robert Shiller’s Cyclically Adjusted ...

For investors hoping President-elect Donald Trump's campaign promises could translate into future stock-market returns, one ...